Display options
Cite
Schoenfeld EM, Soares WE, Schaeffer EM, et al. "This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine. Acad Emerg Med. 2021;doi: 10.1111/acem.14369.
Schoenfeld, E. M., Soares, W. E., Schaeffer, E. M., Gitlin, J., Burke, K., & Westafer, L. M. (2021). "This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, . https://doi.org/10.1111/acem.14369
Schoenfeld, Elizabeth M, et al. ""This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine." Academic emergency medicine : official journal of the Society for Academic Emergency Medicine vol. (2021). doi: https://doi.org/10.1111/acem.14369
Schoenfeld EM, Soares WE, Schaeffer EM, Gitlin J, Burke K, Westafer LM. "This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine. Acad Emerg Med. 2021 Aug 09; doi: 10.1111/acem.14369. Epub 2021 Aug 09. PMID: 34374466.
Copy Download .nbib Format: NLM
Share it on

Acad Emerg Med. 2021 Aug 09; doi: 10.1111/acem.14369. Epub 2021 Aug 09.

"This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine

Elizabeth M Schoenfeld, William E Soares, Emily M Schaeffer, Jacob Gitlin, Kimberly Burke, Lauren M Westafer

Affiliations

  1. Department of Emergency Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.
  2. Institute for Healthcare Delivery and Population Science, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.
  3. University of Massachusetts Medical School, Worcester, Massachusetts, USA.

PMID: 34374466 DOI: 10.1111/acem.14369

Abstract

OBJECTIVES: Despite evidence demonstrating the safety and efficacy of buprenorphine for the treatment of emergency department (ED) patients with opioid use disorder (OUD), incorporation into clinical practice has been highly variable. We explored barriers and facilitators to the prescription of buprenorphine, as perceived by practicing ED clinicians.

METHODS: We conducted semistructured interviews with a purposeful sample of ED clinicians. An interview guide was developed using the Consolidated Framework for Implementation Research and Theoretical Domains Framework implementation science frameworks. Interviews were recorded, transcribed, and analyzed in an iterative process. Emergent themes were identified, discussed, and organized.

RESULTS: We interviewed 25 ED clinicians from 11 states in the United States. Participants were diverse with regard to years in practice and practice setting. While outer setting barriers such as the logistic costs of getting a DEA-X waiver and lack of clear follow-up for patients were noted by many participants, individual-level determinants driven by emotion (stigma), beliefs about consequences and roles, and knowledge predominated. Participants' responses suggested that implementation strategies should address stigma, local culture, knowledge gaps, and logistic challenges, but that a particular order to addressing barriers may be necessary.

CONCLUSIONS: While some participants were hesitant to adopt a "new" role in treating patients with medications for OUD, many already had and gave concrete strategies regarding how to encourage others to embrace their attitude of "this is part of emergency medicine now."

© 2021 Society for Academic Emergency Medicine.

Keywords: MOUD; OUD; barriers; buprenorphine; facilitators; implementation; qualitative

References

  1. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths-United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):2013-2017. - PubMed
  2. Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. doi:10.1136/bmj.j1550 - PubMed
  3. D’Onofrio G, O’Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence. JAMA. 2015;313(16):1636-1639. doi:10.1001/jama.2015.3474 - PubMed
  4. Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137-145. doi:10.7326/M17-3107 - PubMed
  5. Hawk K, Hoppe J, Ketcham E, et al. Consensus recommendations on the treatment of opioid use disorder in the emergency department. Ann Emerg Med. 2021:S0196-0644(21)00306-1. doi:10.1016/j.annemergmed.2021.04.023 - PubMed
  6. Houry D, Adams J. Emergency physicians and opioid overdoses: a call to aid. Ann Emerg Med. 2019;74(3):436-438. doi:10.1016/j.annemergmed.2019.07.020 - PubMed
  7. Strayer RJ, Hawk K, Hayes BD, et al. Management of opioid use disorder in the emergency department: a white paper prepared for the American academy of emergency medicine. J Emerg Med. 2020;58(3):522-546. doi:10.1016/j.jemermed.2019.12.034 - PubMed
  8. Kilaru AS, Xiong A, Lowenstein M, et al. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3(5):e205852-e205913. doi:10.1001/jamanetworkopen.2020.5852 - PubMed
  9. Schoenfeld EM, Westafer LM, Soares WE. Missed opportunities to save lives-treatments for opioid use disorder after overdose. JAMA Netw Open. 2020;3(5):e206369. doi:10.1001/jamanetworkopen.2020.6369 - PubMed
  10. Im D, Chary A, Condella A, et al. Emergency department clinicians’ attitudes toward opioid use disorder and emergency department-initiated buprenorphine treatment: a mixed-methods study. West J Emerg Med. 2020;21(2):261-271. doi:10.5811/westjem.2019.11.44382 - PubMed
  11. Lowenstein M, Kilaru A, Perrone J, et al. Barriers and facilitators for emergency department initiation of buprenorphine: a physician survey. Am J Emerg Med. 2019;37(9):1787-1790. doi:10.1016/j.ajem.2019.02.025 - PubMed
  12. Hawk KF, D’Onofrio G, Chawarski MC, et al. Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine. JAMA Netw Open. 2020;3(5):e204561. doi:10.1001/jamanetworkopen.2020.4561 - PubMed
  13. Foster SD, Lee K, Edwards C, et al. Providing incentive for emergency physician x-waiver training: an evaluation of program success and postintervention buprenorphine prescribing. Ann Emerg Med. 2020;76(2):206-214. doi:10.1016/j.annemergmed.2020.02.020 - PubMed
  14. Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychol. 2015;3(1):32. doi:10.1186/s40359-015-0089-9 - PubMed
  15. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:1-15. - PubMed
  16. Atkins L, Francis J, Islam R, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):1-18. doi:10.1186/s13012-017-0605-9 - PubMed
  17. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277-1288. - PubMed
  18. Varpio L, Ajjawi R, Monrouxe LV, O’Brien BC, Rees CE. Shedding the cobra effect: problematising thematic emergence, triangulation, saturation and member checking. Med Educ. 2016;51:40-50. - PubMed
  19. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item check-list for interviews and focus groups. Int J Qual Health Care. 2007;19:349-357. - PubMed
  20. Dong KA, Lavergne KJ, Salvalaggio G, et al. Emergency physician perspectives on initiating buprenorphine/naloxone in the emergency department: a qualitative study. J Am Coll Emerg Physicians Open. 2021;2:e12409. - PubMed
  21. Practice guidelines for the administration of buprenorphine for treating opioid use disorder. Federal Register. April 28, 2021. Accessed May 28, 2021. https://www.federalregister.gov/documents/2021/04/28/2021-08961/practice-guidelines-for-the-administration-of-buprenorphine-for-treating-opioid-use-disorder - PubMed
  22. Weiner SG, Baker O, Bernson D, Schuur JD. One-year mortality of patients after emergency department treatment for nonfatal opioid overdose. Ann Emerg Med. 2020;75(1):13-17. doi:10.1016/j.annemergmed.2019.04.020 - PubMed
  23. Melnick ER, Nath B, Ahmed OM, et al. Progress report on EMBED: a pragmatic trial of user-centered clinical decision support to implement EMergency department-initiated BuprenorphinE for opioid use Disorder. J Psychiatr Brain Sci. 2020;5:e200003. doi:10.20900/jpbs.20200003 - PubMed
  24. Buprenorphine ED protocol. FOAMCast. Accessed May 28, 2021. https://foamcast.org/opioid-use-disorder/buprenorphineedprotocol/ - PubMed
  25. Stayerisms-opioid abuse and buprenorphine. EM:RAP. September 2018. Accessed May 28, 2021. https://www.emrap.org/episode/emrap2018/strayerisms - PubMed
  26. Prehospital buprenorphine. EM:RAP. April 2021. Accessed May 28, 2021. https://www.emrap.org/episode/emrap2021april/prehospital - PubMed
  27. Bogan C, Jennings L, Haynes L, et al. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state. J Subst Abuse Treat. 2020;112S:73-78 doi:10.1016/j.jsat.2020.02.007 - PubMed

Publication Types

Grant support